Wave Life Sciences Ltd. (WVE) NASDAQ

6.58

+0.04(+0.61%)

Updated at May 09 10:18AM

Currency In USD

Valuation

Market Cap1.71B
Enterprise Value1.43B
P/E Ratio-10.95
PEG Ratio-0.37
Price/Sales Ratio9.36
Price/Book Ratio5.07
Enterprise/Revenue6.81
Enterprise/EBITDA-7.25

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.9
Operating Margin-1.02

Management Effectiveness

Return On Assets-0.28
Return On Equity-1

Income Statement

Revenue108.3M
Revenue/Share0.67
Gross Profit99.64M
EBITDA-101.74M
Net Income-97.01M
Diluted EPS-0.7

Balance Sheet

Total Cash302.08M
Total Cash/Share1.87
Total Debt25.4M
Total Debt/Equity0.12
Current Ratio2.89
Book Value Per Share1.35

Price History

52-Week Change14.24
52-Week High16.74
52-Week Low4.25
Moving Average 50 Days8.22
Moving Average 200 Days9.93

Statistics

Average Volume1.44M
Shares Outstanding154.09M
% Held by Institutions97.79

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A